Antiangiogenesis therapy in the treatment of metastatic colorectal cancer
The process of new blood vessel formation, or angiogenesis, has become an important target for therapeutic intervention in many cancers, including metastatic colorectal cancer (mCRC). The growth and metastasis of primary tumors is dependent upon their ability to acquire and maintain an adequate bloo...
Main Authors: | Axel Grothey MD, Carmen Allegra MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-11-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834012454464 |
Similar Items
-
Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer
by: Vanessa Wookey, et al.
Published: (2021-06-01) -
Mechanisms of resistance to antiangiogenesis therapy.
by: Azam, F, et al.
Published: (2010) -
Review: Medical treatment of advanced colorectal cancer in 2009
by: Axel Grothey
Published: (2009-09-01) -
Hypertension and Antiangiogenesis
by: Rhian M. Touyz, MBBCh, PhD, et al.
Published: (2019-09-01) -
Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
by: Xueting Wan, et al.
Published: (2021-10-01)